Hims & Hers Health Free Cash Flow (FCF) History (HIMS)
Hims & Hers Health reported $57.4M in free cash flow for fiscal 2025, a decrease of 71.05% from the previous fiscal year, with a free cash flow margin of 2.45%.
View full Hims & Hers Health company overviewHims & Hers Health free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $57.4M | −$140.9M | −71.05% | +2.45% |
| 2024 | 2024-12-31 | $198.3M | $151.3M | +322.03% | +13.43% |
| 2023 | 2023-12-31 | $47.0M | $80.7M | — | +5.39% |
| 2022 | 2022-12-31 | −$33.7M | $5.7M | — | −6.40% |
| 2021 | 2021-12-31 | −$39.4M | −$32.7M | — | −14.50% |
| 2020 | 2020-12-31 | −$6.7M | $69.9M | — | −4.51% |
| 2019 | 2019-12-31 | −$76.7M | — | — | −92.85% |
Hims & Hers Health quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$68.2M | $1.3M | — | −9.06% |
| Q1 2026 | 2026-03-31 | $53.1M | $3.0M | +5.92% | +8.72% |
| Q4 2025 | 2025-12-31 | −$2.5M | −$62.0M | — | −0.40% |
| Q3 2025 | 2025-09-30 | $79.3M | −$46,000 | −0.06% | +13.24% |
| Q2 2025 | 2025-06-30 | −$69.5M | −$117.1M | — | −12.76% |
| Q1 2025 | 2025-03-31 | $50.1M | $38.3M | +323.13% | +8.55% |
| Q4 2024 | 2024-12-31 | $59.5M | $48.7M | +451.96% | +12.36% |
| Q3 2024 | 2024-09-30 | $79.4M | $60.1M | +311.85% | +19.76% |
| Q2 2024 | 2024-06-30 | $47.6M | $37.6M | +377.76% | +15.08% |
| Q1 2024 | 2024-03-31 | $11.8M | $4.9M | +69.77% | +4.26% |
| Q4 2023 | 2023-12-31 | $10.8M | $20.1M | — | +4.37% |
| Q3 2023 | 2023-09-30 | $19.3M | $15.2M | +378.90% | +8.50% |
| Q2 2023 | 2023-06-30 | $10.0M | $17.7M | — | +4.79% |
| Q1 2023 | 2023-03-31 | $7.0M | $27.7M | — | +3.66% |
| Q4 2022 | 2022-12-31 | −$9.3M | −$4.7M | — | −5.55% |
| Q3 2022 | 2022-09-30 | $4.0M | $21.6M | — | +2.78% |
| Q2 2022 | 2022-06-30 | −$7.8M | −$7.2M | — | −6.84% |
| Q1 2022 | 2022-03-31 | −$20.7M | −$3.9M | — | −20.43% |
| Q4 2021 | 2021-12-31 | −$4.6M | −$3.0M | — | −5.42% |
| Q3 2021 | 2021-09-30 | −$17.5M | −$19.6M | — | −23.63% |
| Q2 2021 | 2021-06-30 | −$551,000 | $730,000 | — | −0.91% |
| Q1 2021 | 2021-03-31 | −$16.8M | −$10.8M | — | −32.02% |
| Q4 2020 | 2020-12-31 | −$1.6M | — | — | −3.76% |
| Q3 2020 | 2020-09-30 | $2.0M | — | — | +4.94% |
| Q2 2020 | 2020-06-30 | −$1.3M | — | — | −3.57% |
| Q1 2020 | 2020-03-31 | −$5.9M | — | — | −19.68% |
Hims & Hers Health free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$6.7M to $57.4M, a net increase of $64.1M. Hims & Hers Health's latest reported quarter, Q2 2026, generated −$68.2M in free cash flow, an increase of $1.3M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Hims & Hers Health filings at SEC.gov ↗